Navigation Links
Novelos Therapeutics Presents Diapeutic Technology Platform At EMIT: Targeted Radiotherapy International Conference
Date:1/31/2013

lds , Senior Vice President, LHA, Ph: (212) 838-3777, Email: afields@lhai.com, @LHA_IR_PR

This news release contains forward-looking statements.  You can identify these statements by our use of words such as "may," "expect," "believe," "anticipate," "intend," "could," "estimate," "continue," "plans," or their negatives or cognates.  Such statements are valid only as of today, and we disclaim any obligation to update this information.  These statements are only estimates and predictions and are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made.  These statements are based on our current beliefs and expectations as to such future outcomes.  Drug discovery and development involve a high degree of risk.  Factors that might cause such a material difference include, among others, uncertainties related to the ability to attract and retain partners for our technologies, the identification of lead compounds, the successful preclinical development thereof, the completion of clinical trials, the FDA review process and other government regulation, our  pharmaceutical collaborators' ability to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, product pricing and third-party reimbursement.


'/>"/>
SOURCE Novelos Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
2. Novelos Therapeutics Successfully Completes First Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
3. Novelos Therapeutics Prices $5.4 Million Public Offering
4. Novelos Therapeutics to Present at LHA Life Sciences & Medical Technologies Virtual Conference on June 28
5. Novelos Therapeutics to Present at Rodman & Renshaw 14th Annual Healthcare Conference on September 11
6. Novelos Therapeutics And Academic Collaborators Present Three Posters At 2012 World Molecular Imaging Congress
7. Novelos Therapeutics Successfully Completes Second Cohort In Phase 1b Solid Tumor Trial With I-131-CLR1404 (HOT) Cancer-Targeted Molecular Radiotherapeutic
8. Novelos Therapeutics Announces Enrollment of First Patient in Solid Tumor Imaging Trial with I-124-CLR1404 (LIGHT) Cancer-targeted PET Imaging Agent at UW Carbone Cancer Center
9. Novelos Therapeutics Closes $2 Million Private Placement
10. Novelos Therapeutics To Present At The Benchmark 2012 Micro Cap Discovery Investor Conference On November 29
11. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)... and NEW YORK , June 18, 2013 ... BDX ) are accelerating the development of new ... technologies through a new collaboration announced today. This new, three-year ... type 1 diabetes (T1D). Many patients with T1D ... requiring a catheter to be placed in the body for ...
(Date:6/18/2013)... -- Healthgrades, the leading online resource that helps consumers ... hospitals, today issued the Healthgrades Women,s Health ... to Get Your Best Outcome . The report, which ... gynecologic surgery, as well as hospitals that excelled ... the most common hospital-based conditions and procedures, urges ...
(Date:6/18/2013)... Apama Medical, a privately held medical ... atrial fibrillation technologies, today announced the issuance of ... and Trademark Office (USPTO), titled "Low Profile Electrodes". ... use on expandable structures such as balloons used ... "We are grateful to the NSF SBIR ...
Breaking Medicine Technology:JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 2JDRF Extends Collaboration with BD to Develop Combined Infusion and Monitoring Products for People with Type 1 Diabetes 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 2Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 3Healthgrades Recognizes Top Hospitals in Treatment of Maternity Care, Gynecologic Surgery and Women's Health 4
... CID s.r.l., a European company leader in interventional medicine, ... revolutionary drug eluting stent technology during The Drug Eluting ... Wednesday, September 22, 2010.  The lecture, entitled "Status of ... by Alexandre Abizaid, MD, PhD. Chief of Intervention at ...
... pleased to announce the addition of Kenneth ... to further the advancement of the group,s minimally invasive ... neurostimulators . Dr. Alo will serve as Director of ... graduated from Texas A&M University College of Medicine and ...
Cached Medicine Technology:CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010 2Kenneth Alo, M.D., Joins Ascendant Neuro as Director of Neuromodulation and Clinical Research 2Kenneth Alo, M.D., Joins Ascendant Neuro as Director of Neuromodulation and Clinical Research 3
(Date:6/18/2013)... Center clinical researchers have launched an innovative clinical ... the ability of a patient,s own stem cells ... arterial disease (PAD). , Led by Vik ... Hospitals Case Medical Center,s Harrington Heart & Vascular ... Reserve University School of Medicine, the clinical trial ...
(Date:6/18/2013)... 2013 The July 2013 issue of Marie ... Getting Beach Ready,” offers a list of home and doctor’s ... in a bathing suit this summer. The list includes treatment ... smoothing cellulite , and more. (go to goo.gl/aIe4J). , ... of Epione Beverly Hills, “though I would say some of ...
(Date:6/18/2013)... Atlanta (PRWEB) June 18, 2013 ... Cypress Care, ScripNet and Procura Management, today announced ... of chief sales officer. In this position, Leonardo ... support of the company’s strategic growth initiatives. , ... his leadership and expertise, Leonardo brings more than ...
(Date:6/18/2013)... 18, 2013 David Connett, DO, vice ... Medicine for the College of Osteopathic Medicine of the ... been elected president of the Osteopathic Medical Board ... Jr. appointed Connett, a 1984 alumnus of COMP, to ... elected Connett to the position during a conference call. ...
(Date:6/18/2013)... in the mammary gland appear to provide a crucial ... life, and the subsequent development of breast cancer, researchers ... 2013 issue of the journal Cancer Prevention Research ... associated with an increased risk of certain types of ... of social stress to cancer have been hard to ...
Breaking Medicine News(10 mins):Health News:UH Case Medical Center launches novel clinical trial using stem cells to prevent amputation 2Health News:Skin Care – Getting Your Body Beach Ready 2Health News:Healthcare Solutions Appoints Richard Leonardo to Chief Sales Officer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 2Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 3Health News:Fat cells in breast may connect social stress to triple-negative breast cancer 4
... replacement therapy (HRT) may increase the risk of developing asthma ... of print in the journal Thorax . The ... quizzed about their use of HRT and development of asthma ... the women were taking part in the French E3N study, ...
... ... capture the authentic heartbeat of NY Jets Quarterback Mark Sanchez for a CBS Cares public ... is a favorite in broadcasting - this may be the biggest audience to hear the ... ...
... ... The inaugural meeting of The Global Leaders, a networking group of influential ... prestigious Yale Club in New York City on February 9th. There are ... companies, with more than $700 billion in annual revenue, $5 trillion in ...
... ... provider of trace level detection technologies based on the exploitation of Surface-Enhanced ... it has appointed David Burns as its new Chief Executive Officer. He ... diagnostic (IVD) products, with the aim to establish D3 Technologies as a ...
... to take steps to prevent illness , SATURDAY, Feb. 6 ... Vancouver can be champions of their health by following some ... the U.S. Centers for Disease Control and Prevention. , The ... by remembering to "Stop, Wash and Go:" , Stop. ...
... ... the St. Louis Jewish Community Center , ... St. Louis, MO (PRWEB) February 7, 2010 -- The Museum of ImaJewnation will ... located inside the St. Louis Jewish Community Center, Staenberg Family Complex Arts & Education Building ...
Cached Medicine News:Health News:Estrogen-only HRT may increase risk of asthma after menopause 2Health News:Superbowl Heartbeat from Thinklabs Electronic Stethoscope 2Health News:Global Leaders Hold Inaugural Meeting in New York City on February 9, 2010 2Health News:Ground Breaking Molecular Diagnostics Business Appoints New CEO 2Health News:Ground Breaking Molecular Diagnostics Business Appoints New CEO 3Health News:Spectators Need to Prepare for Olympic Games, Too 2
... catheters are designed using established technology ... following benefits:, ,Working with pH ... where the multi-use catheter is used ... contact to the skin.,NOTE: ,Medtronic pH ...
... Slimline single-use pH catheters are ... cross-contamination and allow greater patient comfort ... ,Medtronic pH measurement systems have been ... that allow an accurate room-temperature calibration. ...
The WaveMax is one of the most flexible stainless steel stents due to its unique wave design and has the lowest effective profile, accommodating a 6F sheath up to 7 mm....
... the world of online quality control ... control information and peer group statistics ... introduces a revolutionary internet based format ... Why rely on traditional quality control ...
Medicine Products: